Convexity Labs

EAF

Convexity Analyst · EAF
Speculativelow confidenceTactical · no named thesis
Generated Jun 21, 2026

Analyst Note: GrafTech International Ltd. (EAF)

Date: 2026-06-13 Current Price: $7.71

1. Structural Readiness

State: Context-Only Conservative Entry:Current Price: $7.71 Extension:Breakout Level: — (Not yet defined; requires confirmation of the specific structural high that defines the base) ATR Current: 10.1% (Extreme)

Setup Classification:

  • Volatility Context: The current ATR of 10.1% is classified as Extreme. In the StoryStocks canon, extreme volatility (>8%) correlates with the highest historical severe-loser rate if a trade is entered prematurely. This suggests that while the structure is intact, the price action is currently too noisy to define a precise entry or stop without further consolidation or a confirmed move.

2. Thesis Layer

Thesis Status: Tactical / Setup-Led Macro Thesis: None Named. Assessment: As of 2026-06-13, there is no named secular thesis driving this specific trade. This is a tactical, setup-led name. The conviction must be derived entirely from the quality of the structural setup (which is currently forming) and the immediate business fundamentals provided in the evidence. Do not invent a macro narrative; judge the name strictly on the strength of the order book, pricing power, and the structural integrity of the price action.

3. Business Fundamentals

Company Overview: GrafTech International Ltd. is a global manufacturer of graphite electrodes and petroleum needle coke. Graphite electrodes are consumable products essential for Electric Arc Furnace (EAF) steelmaking, which accounts for approximately 96% of the company's sales (Evidence E18). The company is vertically integrated, being the only large-scale producer substantially integrated into petroleum needle coke manufacturing, its key raw material (Evidence E13).

Key Business Drivers (as of May 2026):

  • Pricing Power: Management announced on March 26, 2026, an increase in graphite electrode prices by a minimum of $600 to $1,200 per metric ton, depending on the region (Evidence E1). This is being applied to uncommitted volume to restore sustainable pricing (Evidence E10).
  • Order Book Visibility: As of the May 1, 2026 earnings call, more than 85% of the anticipated 2026 volume was already committed in the order book, tracking ahead of the prior year (Evidence E2, E9).
  • Volume Growth: The company expects a 5% to 10% year-over-year increase in total sales volume for 2026, reflecting market share gains (Evidence E3). Q1 2026 sales volume was 28.1 thousand MT, a 14% increase year-over-year, with U.S. sales volume growing 37% (Evidence E8, E16).
  • Cost Management: Management expects a modest year-over-year reduction in cash costs, consistent with guidance, and a low single-digit percentage-point decline in cash cost of goods sold per MT for 2026 compared to 2025 (Evidence E4, E11).
  • Trade Environment: The International Trade Commission announced a preliminary determination in April 2026 regarding material injury from imports from China and India, supporting domestic pricing power (Evidence E7).
  • Structural Demand: The shift toward EAF steelmaking (driven by decarbonization) and the demand for petroleum needle coke in EV/ESS battery applications are cited as long-term growth drivers (Evidence E5, E6, E14, E15).

4. Archetype and Conviction

Archetype: Growth Leader (with Cyclical Recovery characteristics) Fit: The name fits the "Growth Leader" archetype due to the double-digit volume growth in Q1 (14%), the 37% U.S. volume surge, and the explicit guidance for 5-10% full-year volume growth. The pricing actions and trade case support suggest a cyclical recovery in margins, but the primary driver is volume expansion and market share capture.

Valuation & Financial Context:

  • Financial Spine: The forward consensus EPS for FY1 is -5.73 and FY2 is -3.76 (Evidence E26).
  • Conviction Analysis:
  • Thesis Strength: Low (No named macro thesis; purely tactical).
  • Evidence Quality: High. The evidence block is robust, citing specific pricing actions, order book percentages, and volume growth figures from primary sources (earnings transcripts and SEC filings).
  • Structural Quality: Moderate. The setup is "Forming," meaning the structure is present but unconfirmed. The extreme ATR (10.1%) is a significant negative factor for structural quality, indicating high noise and risk of false breakouts.
  • Rerating Potential: Dependent on the confirmation of the price increase pass-through and the successful execution of the volume guidance. The negative EPS consensus suggests the market is currently pricing in a loss, which could lead to a rerating if the pricing actions and volume growth translate to profitability sooner than expected.

Summary: The business fundamentals are strong (high visibility, pricing power, volume growth), but the technical setup is currently in a "Forming" state with extreme volatility. The negative EPS consensus creates a divergence between the operational momentum and the financial market expectations.

5. Invalidations, Strengtheners, and Gaps

Invalidation:

  • Fundamental: A significant miss on the 5-10% volume guidance or a failure to pass through the $600-$1,200 price increases due to customer pushback or trade case delays.

Strengtheners:

  • Technical: A confirmed breakout above the structural resistance level with volume, followed by a retest that holds above the breakout level.
  • Fundamental: Confirmation that the price increases are fully realized in the next quarter's margins, or an upgrade in the trade case determination from "preliminary" to "final" affirmative.

Gaps in Evidence:

  • Profitability Path: While volume and pricing are strong, the financial spine shows negative EPS for FY1 and FY2. There is no specific evidence in the provided block detailing *when* the company expects to return to positive EPS or the specific margin targets required to achieve this.
  • Capex/Lead Times: No specific data on capital expenditure plans or lead times for new capacity to meet the growing demand.
  • Commodity Prices: While needle coke demand is cited, specific spot price trends for petroleum needle coke are not detailed in the evidence beyond the general demand thesis.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: low Key evidence: 85%+ of 2026 volume committed in order book; Q1 sales volume up 14% YoY with 37% U.S. growth; Management announced $600-$1,200/MT price increases effective March 2026. Key risks: Extreme ATR of 10.1% indicates severe volatility and high risk of false breakouts; Forward consensus EPS remains deeply negative (-5.73 FY1); Setup is forming but not confirmed; Trade case outcome remains preliminary. Sizing hint: Position size should be minimal or zero until a confirmed breakout occurs; extreme volatility requires significant risk buffer. Expected path: Management expects 5-10% volume growth and margin improvement via price hikes; price action likely to remain volatile while the forming coil structure consolidates before a potential breakout. Expected horizon: 3 to 6 months for structural confirmation or invalidation.

Loading chart...
Exhibit 1: EAF daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for EAF.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for EAF.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: